GHK-Cu Peptide buy Tripeptide for “anti-aging” intended for research. It is a small natural peptide with immense therapeutic potential. GHK-Cu has several biological activities against aging and modulates the expression of about 30% of human genes. We supply sublingual form for use in research only. Our online store has a choice in GHK-CU for all of you study needs. You can buy GHK-CU HERE TODAY!
- GHK-Cu 50mg (Copper Peptide) $70.00
- GHK-Cu 200mg (Copper Peptide) $200.00
- GHK-Cu 500mg (Copper Peptide) $330.00
- GHK-Cu 1000mg (Copper Peptide) $500.00
What is GHK-Cu?
The tripeptide glycyhistidyl-lysine (GHK) is a small molecule composed of three short chains of amino acids. We find it in biological liquids in free form or in the form of a complex that forms with the Cu2+ ion (GHK-Cu).
Typically the concentration in blood is about 200 µg l−1 between the ages of 20 and 25 years, but it decreases to 80 µg l−1 after 60 years.
Its therapeutic potential is immense: it has numerous biological activities linked to ageing or skin treatments. Its mechanism of action lies in the reconfiguration of the average expression of genes, as found in young and healthy individuals.
What are the Effects of GHK on Aging?
Ageing and its pathologies result from progressive degradation of the quality and use of our genes. Over the years, experts have seen gene activity is responsible for repairing anomalies and an increase in the training of genes linked to inflammation and tissue destruction.
For a long time, research has been discovering the exact mechanism involved in this phenomenon. But, in reality, data shows us numerous mechanisms involved and that thousands of genes are at stake.
GHK responds perfectly to this problem as it seems to be able to reconfigure the activity of an incalculable number of genes. Or moreover, correct this activity so that it is closer to that of young people.
Therefore, it may constitute a potential advance in preventing and treating ageing conditions, such as cancer, Alzheimer’s disease, retinopathies, atherosclerosis, etc.
How is GHK-Cu Made?
GHK comes from researchers who wanted to compare young people’s blood with that of people over 50. They realized that the blood of the youngest tended to inhibit the synthesis of fibrinogen, a protein involved in numerous pathological processes. By deepening the question, they were able to identify the active factor, which is GHK.
Dozens of studies have shown that this simple molecule can:
-improve wound healing
-promote tissue regeneration (particularly those of the skin, scalp, bones, and liver)
-increase collagen synthesis
-can improve angiogenesis and neurogenesis
-have antioxidant and anti-inflammatory effects
GHK-Cu Peptide Buy for Anti-Aging Research
Researchers at the Department of Defense are funding a $7.8 million pilot project to develop a peptide to reduce aging and maintain youth in lab rats. The grant was announced last week, following some controversy over whether human subjects would be eligible to receive funding. “This grant funds studies on the beneficial effects of GHK-Cu peptides in aging laboratory animals,” said Dr. J. Randall Thompson, deputy secretary of defence for acquisition, technology, and logistics, in a statement. “These studies are part of an ambitious Pentagon plan to identify, validate, and develop new strategies to significantly impact aging processes in healthy, uninjured, young laboratory animals, and eventually human subjects.”
The GHK-Cu peptide is a product developed by a Massachusetts biotech company called GHR. The peptide consists of copper, known to affect gene expression, and a protein. In an e-mail, a GHR spokeswoman told Consumerist that the company is confident the pilot study will show that the peptide has been able to halt the aging process. “This project’s primary objective is to study the health effects of administering GHK-Cu to aged mice and rats,” wrote the spokeswoman. “At the end of the year, we will determine whether the mice and rats that received GHK-Cu lived longer than those that did not receive the peptide.”
The GHR spokeswoman pointed out that this study does not involve human subjects. Although the research could potentially have some military applications, it is purely scientific. “The administration of GHK-Cu to animals that are genetically similar to humans could eventually lead to more effective interventions in improving the health of human beings,” the spokeswoman wrote.
GHK-CU Peptide Comments
“I think it’s a good thing that some people will take a hard look at the science and help develop a better, safer, more targeted method of anti-aging treatment. Of course, there is a little bit of a concern for the “bait & switch” aspect – which is that the studies with humans may not work out like the study on the rats and the mice. But at the same time, we need more medical and scientific studies to show that these anti-aging therapies actually work, are safe and effective, and are even better than the old methods of aging prevention – such as maintaining a healthy diet and exercising regularly.”
What Does GHK-Cu Peptide Do?
The FDA approval process for using GHK-Cu peptides as anti-aging treatment for human subjects seems to be in place. From the story: Although the government-backed research is in its early stages, the Pentagon hopes to start a yearlong study with lab mice next year to see whether the GHK-Cu peptides have potential applications in delaying or reversing aging. “We are interested in understanding and identifying new molecular targets and mechanisms of aging. We are looking for the potential use of a peptide called GHK-Cu peptides to delay the aging process,” R. Douglas Auerbach, deputy under secretary of defense for acquisition, technology, and logistics, told Defense News in a May 3 telephone interview. “We think that it has a lot of promise.”
In October, the Defense Department announced it would fund $7.8 million to Dr. Thomas Witte, of the Gerontology Research Center at the Massachusetts Institute of Technology to study the mechanism of GHK-Cu peptides in aging research with lab mice and rats.
Research with GHK-CU Reviews
Dr. Witte will use a high-fat diet to slow down the aging process in lab animals and investigate the effects of GHK-Cu peptides on genes and proteins involved in the aging process. This is a bit disingenuous. If the goal is to understand the impact of GHK-Cu peptides on aging, why not study the aging process in mice and rats that already have that process?
The reason is simple — these animals are cheaper, easier to handle, and more likely to live long enough to give data and do a study. There’s no need to get expensive, delicate humans involved. Plus, no need to worry about whether any of them will be alive next week (as the study will take several years). And it takes a lot less time and money. It is an excellent way of saying that experts did the study in rats and mice but not in humans. There are already people aging; why not use them?
I think the FDA is already involved – I can’t see how the FDA wouldn’t give its blessing on the research. As for the fact that they’re “interested” in anti-aging research, the term “interested” means “the military is researching because they want to find something that might be useful someday“, And the military certainly has a well-developed history of developing such things.
GHK-CU Before and After
Whether or not they end up using the information to benefit people is a different matter. In this case, the “mice and rats” that the article says will be studied “are genetically similar to humans”, – so it looks like the military will get its way. If you’re using humans, though, go through proper channels, make sure the studies are appropriate and ethical, and do it to your subjects. I don’t think the military has the right to drop a bunch of money on studies just because they want to see what happens.
At least they aren’t asking for an FDA approval – the problem with what they’ve been doing up to now is that it’s like asking for a review to see whether your dog has hip dysplasia (that’s a real condition), you don’t normally have to get approval to do the study, and if you do something wrong, or the results don’t go the way you think they should, it’s not that easy to stop. You can’t just give away money to someone like the military and leave it up to them to decide what to do with the results. I don’t know if this is exactly how the study will work out, but this is how I see it:
It’s a lot cheaper, faster, and easier to use lab animals than it is to use people to study anti-aging treatments, which is why we don’t see too much research on it. When the military goes in and does it, they’re going to want to make sure they get the right results, or else they can’t use what they’ve found – so they’re going to want to do it in a systematic, controlled manner, and do a study where you can be sure they know what they’re looking for.